Evidence map›Paper›PMID 35429463›Full record

SynthesisThe Lancet. Infectious diseases2022

Defining the determinants of vaccine uptake and undervaccination in migrant populations in Europe to improve routine and COVID-19 vaccine uptake: a systematic review.

Alison F Crawshaw, Yasmin Farah, Anna Deal, Kieran Rustage, Sally E Hayward, Jessica Carter, Felicity Knights, Lucy P Goldsmith, Ines Campos-Matos, Fatima Wurie and 4 more

Open access · greenAbstract readSystematic Review
In one paragraph

Synthesis in The Lancet. Infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 143 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
143citing papers in PubMed, 10 pooled it
36.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

143 citing papers in PubMed, 10 syntheses or guidelines pooled it, 233 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. "Vaccinating your child during an emergency is more important than ever": a randomised controlled trial on message framing among Ukrainian refugees in Poland, 2023.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024
    Trial
  12. Trial
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

83 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Alison F CrawshawThe Migrant Health Research Group, Institute for Infection and Immunity, St George's, University of London, London, UK.
Yasmin FarahThe Migrant Health Research Group, Institute for Infection and Immunity, St George's, University of London, London, UK.
Anna DealThe Migrant Health Research Group, Institute for Infection and Immunity, St George's, University of London, London, UK; Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, UK.
Kieran RustageThe Migrant Health Research Group, Institute for Infection and Immunity, St George's, University of London, London, UK.
Sally E HaywardThe Migrant Health Research Group, Institute for Infection and Immunity, St George's, University of London, London, UK; Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, UK.
Jessica CarterThe Migrant Health Research Group, Institute for Infection and Immunity, St George's, University of London, London, UK.
Felicity KnightsThe Migrant Health Research Group, Institute for Infection and Immunity, St George's, University of London, London, UK.
Lucy P GoldsmithThe Migrant Health Research Group, Institute for Infection and Immunity, St George's, University of London, London, UK.
Ines Campos-MatosOffice for Health Improvement and Disparities, Department of Health and Social Care, London, UK; UK Health Security Agency, London, UK.
Fatima WurieOffice for Health Improvement and Disparities, Department of Health and Social Care, London, UK; UK Health Security Agency, London, UK.
Azeem MajeedDepartment of Primary Care and Public Health, Imperial College London, London, UK.
Helen BedfordPopulation, Policy and Practice Department, UCL Great Ormond Street Institute of Child Health, London, UK.
Alice S ForsterOur Future Health, Manchester, UK.
Sally HargreavesThe Migrant Health Research Group, Institute for Infection and Immunity, St George's, University of London, London, UK. Electronic address: s.hargreaves@sgul.ac.uk.
St George's, University of London · GBDepartment of Health and Social Care · GBFaculty of Public Health · GBImperial College London · GBUniversity College London · GB

Funding

Medical Research Council MRC/N013638/1
6 · The paper itself

Abstract

Understanding why some migrants in Europe are at risk of underimmunisation and show lower vaccination uptake for routine and COVID-19 vaccines is critical if we are to address vaccination inequities and meet the goals of WHO's new Immunisation Agenda 2030. We did a systematic review (PROSPERO: CRD42020219214) exploring barriers and facilitators of vaccine uptake (categorised using the 5As taxonomy: access, awareness, affordability, acceptance, activation) and sociodemographic determinants of undervaccination among migrants in the EU and European Economic Area, the UK, and Switzerland. We searched MEDLINE, CINAHL, and PsycINFO from 2000 to 2021 for primary research, with no restrictions on language. 5259 data sources were screened, with 67 studies included from 16 countries, representing 366 529 migrants. We identified multiple access barriers-including language, literacy, and communication barriers, practical and legal barriers to accessing and delivering vaccination services, and service barriers such as lack of specific guidelines and knowledge of health-care professionals-for key vaccines including measles-mumps-rubella, diphtheria-pertussis-tetanus, human papillomavirus, influenza, polio, and COVID-19 vaccines. Acceptance barriers were mostly reported in eastern European and Muslim migrants for human papillomavirus, measles, and influenza vaccines. We identified 23 significant determinants of undervaccination in migrants (p<0·05), including African origin, recent migration, and being a refugee or asylum seeker. We did not identify a strong overall association with gender or age. Tailored vaccination messaging, community outreach, and behavioural nudges facilitated uptake. Migrants' barriers to accessing health care are already well documented, and this Review confirms their role in limiting vaccine uptake. These findings hold immediate relevance to strengthening vaccination programmes in high-income countries, including for COVID-19, and suggest that tailored, culturally sensitive, and evidence-informed strategies, unambiguous public health messaging, and health system strengthening are needed to address access and acceptance barriers to vaccination in migrants and create opportunities and pathways for offering catch-up vaccinations to migrants.

Indexed as

COVID-19MeaslesTransients and MigrantsVaccinesCOVID-19 VaccinesEuropeHealth Services AccessibilityHumansVaccinationCOVID-19 VaccinesVaccines

Identifiers

PMID35429463
PMCPMC9007555
OpenAlexW4224023453

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.